Antagonism of Activin by Activin Chimeras

Allendorph, 2006, Structure of the ternary signaling complex of a TGF-beta superfamily member, Proc. Natl. Acad. Sci. USA, 103, 7643, 10.1073/pnas.0602558103

Babitt, 2005, Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor, J. Biol. Chem., 280, 29820, 10.1074/jbc.M503511200

Babitt, 2006, Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression, Nat. Genet., 38, 531, 10.1038/ng1777

Barbara, 1999, Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily, J. Biol. Chem., 274, 584, 10.1074/jbc.274.2.584

Benchabane, 2003, GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations, Mol. Cell. Biol., 23, 6646, 10.1128/MCB.23.18.6646-6661.2003

Bertolino, 2008, Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function, Proc. Natl. Acad. Sci. USA, 105, 7246, 10.1073/pnas.0801285105

Bocharov, 2002, Dynamics-modulated biological activity of transforming growth factor beta3, J. Biol. Chem., 277, 46273, 10.1074/jbc.M206274200

Brown, 2005, Crystal structure of BMP-9 and functional interactions with pro-region and receptors, J. Biol. Chem., 280, 25111, 10.1074/jbc.M503328200

Chen, 2006, Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis, Exp. Biol. Med. (Maywood), 231, 534, 10.1177/153537020623100507

Cheng, 2003, Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs), J. Bone Joint Surg. Am., 85-A, 1544, 10.2106/00004623-200308000-00017

David, 2007, Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells, Blood, 109, 1953, 10.1182/blood-2006-07-034124

Deal, 2009, Potential new drug targets for osteoporosis, Nat. Clin. Pract. Rheumatol., 5, 20, 10.1038/ncprheum0977

Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-beta family signalling, Nature, 425, 577, 10.1038/nature02006

Duncan, 2001, BMPs on the road to hepatogenesis, Genes Dev., 15, 1879, 10.1101/gad.920601

Ehata, 2007, Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line, Cancer Sci., 98, 127, 10.1111/j.1349-7006.2006.00357.x

Fischer, 2003, Residues in the C-terminal region of activin A determine specificity for follistatin and type II receptor binding, J. Endocrinol., 176, 61, 10.1677/joe.0.1760061

Gilboa, 2000, Bone morphogenetic protein receptor complexes on the surface of live cells: A new oligomerization mode for serine/threonine kinase receptors, Mol. Biol. Cell, 11, 1023, 10.1091/mbc.11.3.1023

Goumans, 2003, Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling, Mol. Cell, 12, 817, 10.1016/S1097-2765(03)00386-1

Gray, 2003, Cripto forms a complex with activin and type II activin receptors and can block activin signaling, Proc. Natl. Acad. Sci. USA, 100, 5193, 10.1073/pnas.0531290100

Greenwald, 2003, The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly, Mol. Cell, 11, 605, 10.1016/S1097-2765(03)00094-7

Groppe, 2008, Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding, Mol. Cell, 29, 157, 10.1016/j.molcel.2007.11.039

Harrington, 2006, Structural basis for the inhibition of activin signalling by follistatin, EMBO J., 25, 1035, 10.1038/sj.emboj.7601000

Harrison, 2004, An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors, J. Biol. Chem., 279, 28036, 10.1074/jbc.M402782200

Heldin, 1997, TGF-beta signalling from cell membrane to nucleus through SMAD proteins, Nature, 390, 465, 10.1038/37284

Hjelmeland, 2004, SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility, Mol. Cancer Ther., 3, 737, 10.1158/1535-7163.737.3.6

Ishikawa, 1995, Truncated type II receptor for BMP-4 induces secondary axial structures in Xenopus embryos, Biochem. Biophys. Res. Commun., 216, 26, 10.1006/bbrc.1995.2587

Johnson, 1996, Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2, Nat. Genet., 13, 189, 10.1038/ng0696-189

Kanamaru, 2001, Smad7 is induced by norepinephrine and protects rat hepatocytes from activin A-induced growth inhibition, J. Biol. Chem., 276, 45636, 10.1074/jbc.M105302200

Keller, 2004, Molecular recognition of BMP-2 and BMP receptor IA, Nat. Struct. Mol. Biol., 11, 481, 10.1038/nsmb756

Kirsch, 2000, Crystal structure of the BMP-2-BRIA ectodomain complex, Nat. Struct. Biol., 7, 492, 10.1038/75903

Korupolu, 2008, Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin, J. Biol. Chem., 283, 3782, 10.1074/jbc.M704530200

Kotzsch, 2009, Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity, EMBO J., 28, 937, 10.1038/emboj.2009.37

Lee, 2005, Regulation of muscle growth by multiple ligands signaling through activin type II receptors, Proc. Natl. Acad. Sci. USA, 102, 18117, 10.1073/pnas.0505996102

Lewis, 2000, Betaglycan binds inhibin and can mediate functional antagonism of activin signaling, Nature, 404, 411, 10.1038/35006129

Ling, 1986, Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin, Nature, 321, 779, 10.1038/321779a0

Liu, 2006, Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling, J. Endocrinol., 189, 409, 10.1677/joe.1.06420

Massague, 1998, TGF-beta signal transduction, Annu. Rev. Biochem., 67, 753, 10.1146/annurev.biochem.67.1.753

Mathews, 1991, Expression cloning of an activin receptor, a predicted transmembrane serine kinase, Cell, 65, 973, 10.1016/0092-8674(91)90549-E

McAllister, 1994, Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1, Nat. Genet., 8, 345, 10.1038/ng1294-345

Mittl, 1996, The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: Implications for receptor binding, Protein Sci., 5, 1261, 10.1002/pro.5560050705

Muenster, 2005, An activin-A/C chimera exhibits activin and myostatin antagonistic properties, J. Biol. Chem., 280, 36626, 10.1074/jbc.M507236200

Nohe, 2002, The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways, J. Biol. Chem., 277, 5330, 10.1074/jbc.M102750200

Oh, 2000, Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis, Proc. Natl. Acad. Sci. USA, 97, 2626, 10.1073/pnas.97.6.2626

Onichtchouk, 1999, Silencing of TGF-beta signalling by the pseudoreceptor BAMBI, Nature, 401, 480, 10.1038/46794

Pearsall, 2008, A soluble activin type IIA receptor induces bone formation and improves skeletal integrity, Proc. Natl. Acad. Sci. USA, 105, 7082, 10.1073/pnas.0711263105

Phillips, 2000, Regulation of activin's access to the cell: Why is mother nature such a control freak?, Bioessays, 22, 689, 10.1002/1521-1878(200008)22:8<689::AID-BIES2>3.0.CO;2-5

Rebbapragada, 2003, Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis, Mol. Cell. Biol., 23, 7230, 10.1128/MCB.23.20.7230-7242.2003

Renlund, 2007, Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor, J. Endocrinol., 195, 95, 10.1677/JOE-07-0281

Risbridger, 2001, Activins and inhibins in endocrine and other tumors, Endocr. Rev., 22, 836, 10.1210/er.22.6.836

Rosenzweig, 1995, Cloning and characterization of a human type II receptor for bone morphogenetic proteins, Proc. Natl. Acad. Sci. USA, 92, 7632, 10.1073/pnas.92.17.7632

Samad, 2005, DRAGON, a bone morphogenetic protein co-receptor, J. Biol. Chem., 280, 14122, 10.1074/jbc.M410034200

Scharpfenecker, 2007, BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis, J. Cell Sci., 120, 964, 10.1242/jcs.002949

Scherner, 2007, Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling, J. Biol. Chem., 282, 13934, 10.1074/jbc.M611062200

Schubert, 1990, Activin is a nerve cell survival molecule, Nature, 344, 868, 10.1038/344868a0

Shi, 2003, Mechanisms of TGF-beta signaling from cell membrane to the nucleus, Cell, 113, 685, 10.1016/S0092-8674(03)00432-X

Song, 1995, Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation, Endocrinology, 136, 4293, 10.1210/en.136.10.4293

Syed, 1998, Efficiency of signalling through cytokine receptors depends critically on receptor orientation, Nature, 395, 511, 10.1038/26773

ten Dijke, 1994, Characterization of type I receptors for transforming growth factor–beta and activin, Science, 264, 101, 10.1126/science.8140412

Thompson, 2003, Structures of an ActRIIB:Activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions, EMBO J., 22, 1555, 10.1093/emboj/cdg156

Tsuchida, 1993, Cloning and characterization of a transmembrane serine kinase that acts as an activin type I reseptor, Proc. Natl. Acad. Sci. USA, 90, 11242, 10.1073/pnas.90.23.11242

Tsuchida, 2000, Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family, J. Biol. Chem., 275, 40788, 10.1074/jbc.M006114200

Tsukazaki, 1998, SARA, a FYVE domain protein that recruits Smad2 to the TGF beta receptor, Cell, 95, 779, 10.1016/S0092-8674(00)81701-8

Vale, 1986, Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid, Nature, 321, 776, 10.1038/321776a0

Vitt, 2001, Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules, Mol. Endocrinol., 15, 681, 10.1210/me.15.5.681

Weber, 2007, A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor, BMC Struct. Biol., 7, 6, 10.1186/1472-6807-7-6

Werner, 2003, Regulation of wound healing by growth factors and cytokines, Physiol. Rev., 83, 835, 10.1152/physrev.2003.83.3.835

Whitman, 1998, Smads and early developmental signaling by the TGFbeta superfamily, Genes Dev., 12, 2445, 10.1101/gad.12.16.2445

Wozney, 1988, Novel regulators of bone formation: Molecular clones and activities, Science, 242, 1528, 10.1126/science.3201241

Xia, 2007, Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4, J. Biol. Chem., 282, 18129, 10.1074/jbc.M701679200

Yamashita, 1995, Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects, J. Cell Biol., 130, 217, 10.1083/jcb.130.1.217

Yu, 2005, Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells, J. Biol. Chem., 280, 24443, 10.1074/jbc.M502825200